• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Inhibiting Sirtuins Can Treat Alzheimer's

sirtuins

  • Please log in to reply
No replies to this topic

#1 osris

  • Guest
  • 531 posts
  • 81

Posted 19 February 2024 - 12:41 PM


Chat GPT article:
 
Inhibiting Sirtuins Can Treat Alzheimer's
 
 
The extracts you provided offer insights into the potential roles of nicotinamide (NAM) and nicotinic acid (niacin or vitamin B3) in Alzheimer's disease (AD) and cognitive decline. Here's a coherent summary:
 
1. Nicotinamide (NAM) and Alzheimer's Disease: Studies suggest that NAM, a form of vitamin B3, could have beneficial effects in Alzheimer's disease. Research conducted on transgenic mice with Alzheimer's-like symptoms demonstrated that NAM, by inhibiting sirtuins, could improve cognitive deficits associated with the disease pathology. It works by reducing the levels of a specific form of tau protein associated with cellular structure breakdown. By stabilizing microtubules and preventing tau protein accumulation, NAM shows promise as a potential treatment for Alzheimer's and similar conditions.
 
2. Dietary Niacin and Cognitive Decline: A large prospective study investigated the association between dietary niacin intake and cognitive decline. Findings indicated that higher niacin intake was inversely associated with the development of Alzheimer's disease and cognitive decline. Participants with higher niacin intake experienced a slower annual rate of cognitive decline. These protective effects were observed even after adjusting for various factors such as age, sex, race, education, and genetic predisposition (ApoE e4 status).
 
3. Nicotinic Acid (Niacin) in Alzheimer's Research: While nicotinamide has received more attention in AD research due to its role in NAD⁺ metabolism and neuroprotective potential, studies on nicotinic acid in the context of AD are relatively limited. Nicotinic acid shares similarities with nicotinamide in NAD⁺ metabolism, but there's less evidence supporting its efficacy in AD compared to nicotinamide. Clinical trials specifically evaluating nicotinic acid's effects on AD patients are lacking, highlighting the need for further research.
 
In summary, both nicotinamide and niacin (nicotinic acid) show promise in Alzheimer's research, with nicotinamide having received more attention and evidence supporting its potential benefits in preclinical studies. However, dietary intake of niacin appears to be associated with protective effects against cognitive decline and AD development, emphasizing the importance of exploring various forms of vitamin B3 in neurodegenerative diseases.
 
The research discussed in the first excerpt suggests that sirtuins, a class of proteins involved in regulating various cellular processes including aging and metabolism, are implicated in Alzheimer's disease (AD). Specifically, the inhibition of sirtuins by compounds like nicotinamide (NAM) appears to have a beneficial effect on cognitive deficits associated with AD pathology in transgenic mouse models. This finding suggests that sirtuins may play a role in the development or progression of AD, making them a potential target for therapeutic interventions aimed at treating or preventing the disease.
 
The research implicating sirtuins in Alzheimer's disease could be seen as concerning for individuals aiming to boost longevity by increasing NAD+ levels to enhance sirtuin activity. Sirtuins have been associated with various benefits related to aging and longevity, and strategies to elevate NAD+ levels, such as through nicotinamide riboside supplementation, have gained attention for their potential to promote healthspan and longevity.
 
However, the findings suggesting a link between sirtuin inhibition and cognitive improvement in Alzheimer's disease raise questions about the potential dual roles of sirtuins in different contexts. While enhancing sirtuin activity may have beneficial effects in some aspects of aging, it's possible that excessive activation or dysregulation of sirtuins could contribute to the pathology of certain age-related diseases like Alzheimer's.
 
Further research is needed to better understand the complex roles of sirtuins in health and disease, as well as the potential risks and benefits of interventions aimed at modulating their activity for longevity purposes. It underscores the importance of careful consideration and balance in pursuing strategies to promote healthy aging and longevity.
 
 
 
 
 
 

  • Informative x 1





Also tagged with one or more of these keywords: sirtuins

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users